Some voters in Florida are considering a ballot question about using genetically modified mosquitos to halt the spread of disease.
The kit is a qualitative nucleic acid assay designed to test for Zika, dengue, and chikungunya viruses simultaneously.
Organizations are pursuing various approaches to control mosquitos harboring dengue and Zika viruses, Technology Review reports.
The deal gives Bio-Rad licensing rights to a PCR-based platform and an assay that improves diagnostic sensitivity and efficacy across four dengue serotypes.
The College Station, Texas-based firm is developing a multiplex, one-step system to diagnose all four dengue serotypes.
The automated device was able to detect pathogens from clinical samples and can be built from a 3D printer retailing at $750 or less.
The firm expands its portfolio, providing customers with Dx for multiple applications
The US Food and Drug Administration has granted Emergency Use Authorization to a real-time PCR test for Dengue, chikungunya, and Zika viruses.
In PLOS this week: metabolomics signature of dengue disease progression, patterns of diversity in Pseudomonas fluorescens, and more.
The South Korean company said the kit not only detects Zika, but is also set up to find multiple mosquito-borne diseases such as Dengue and Chikunguya.
In Science this week: genetic analysis of pollutant-tolerant fish, and more.
Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.
New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.
NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.